Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant can completely inhibit the activity of 17b-estradiol (E2) with IC50 value of 6.4 nM, and inhibit the proliferation of MCF7 and CAMA-1 cells with IC50 value of 1.4-1.6 nM. Palazestrant can inhibit ER+/HER2+ cancer
Specification: ≥98%
Molecular Formula: C28H36FN3O
Molecular Weight: 449.60
- UPC:
- 41114802
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P757084-1mg
- CAS:
- 2092925-89-6
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





